{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:14:11Z","timestamp":1788315251555,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Necroptosis, a form of programmed cell death, has emerged as a promising therapeutic target. Although several RIPK1 inhibitors have demonstrated favorable safety profiles in clinical trials, clinical translation of necroptosis-targeted therapies remains limited by modest efficacy, limited specificity, and species-specific activity of compounds such as necrosulfonamide (NSA). To resolve these challenges, this study identified a potential necroptosis inhibitor from a clinical drug library. Apomorphine (APO), a non-addictive morphine derivative used to treat Parkinson\u2019s disease, was found to inhibit necroptosis by sterically blocking key residues involved in mixed lineage kinase domain-like protein (MLKL) activation and oligomerization, as confirmed by nuclear magnetic resonance analysis. APO is redox sensitive and prone to auto-oxidation. The oxidized form of APO (Ox-APO) showed stronger binding to MLKL than the reduced form of APO (Re-APO), as demonstrated by surface plasmon resonance analysis. Ox-APO significantly ameliorated tissue damage in two murine necroptosis models: dextran sulfate sodium (DSS)-induced colitis and acetaminophen (APAP)-induced liver injury. Collectively, these data highlight the therapeutic potential of APO as a necroptosis-specific inhibitor in necroptosis-related diseases in both humans and mice.<\/jats:p>","DOI":"10.1038\/s41420-025-02763-8","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T06:56:18Z","timestamp":1760338578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Apomorphine is a novel necroptosis inhibitor targeting mixed lineage kinase domain-like protein oligomerization"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3009-6636","authenticated-orcid":false,"given":"Myeonggil","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hyun","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man Sup","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2190-5469","authenticated-orcid":false,"given":"In Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9690-0553","authenticated-orcid":false,"given":"Woo Joong","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Sue","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunkyeong","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Je-Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4636-5745","authenticated-orcid":false,"given":"Cheol Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Doo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3015-2059","authenticated-orcid":false,"given":"Taebo","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung-Seok","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8294-3234","authenticated-orcid":false,"given":"Jeon-Soo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"2763_CR1","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nchembio711","volume":"1","author":"A Degterev","year":"2005","unstructured":"Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol. 2005;1:112\u20139.","journal-title":"Nat Chem Biol"},{"key":"2763_CR2","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.molcel.2007.04.021","volume":"26","author":"YS Kim","year":"2007","unstructured":"Kim YS, Morgan MJ, Choksi S, Liu ZG. TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. Mol Cell. 2007;26:675\u201387.","journal-title":"Mol Cell"},{"key":"2763_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-1-4939-8754-2_12","volume":"1857","author":"M Zelic","year":"2018","unstructured":"Zelic M, Kelliher MA. Analyzing necroptosis using an RIPK1 kinase inactive mouse model of TNF shock. Methods Mol Biol. 2018;1857:125\u201334.","journal-title":"Methods Mol Biol"},{"key":"2763_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","volume":"148","author":"L Sun","year":"2012","unstructured":"Sun L, Wang H, Wang Z, He S, Chen S, Liao D, et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell. 2012;148:213\u201327.","journal-title":"Cell"},{"key":"2763_CR5","doi-asserted-by":"crossref","unstructured":"Huang D, Zheng X, Wang ZA, Chen X, He WT, Zhang Y, et al. The MLKL channel in necroptosis is an octamer formed by tetramers in a dyadic process. Mol Cell Biol. 2017;37:e00497-16.","DOI":"10.1128\/MCB.00497-16"},{"key":"2763_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23004-3","volume":"12","author":"JY Baik","year":"2021","unstructured":"Baik JY, Liu Z, Jiao D, Kwon HJ, Yan J, Kadigamuwa C, et al. ZBP1 not RIPK1 mediates tumor necroptosis in breast cancer. Nat Commun. 2021;12:2666.","journal-title":"Nat Commun"},{"key":"2763_CR7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25:486\u2013541.","journal-title":"Cell Death Differ"},{"key":"2763_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.immuni.2013.02.003","volume":"38","author":"A Kaczmarek","year":"2013","unstructured":"Kaczmarek A, Vandenabeele P, Krysko DV. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity. 2013;38:209\u201323.","journal-title":"Immunity"},{"key":"2763_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1126\/science.285.5425.248","volume":"285","author":"HC Wang","year":"1999","unstructured":"Wang HC, Bloom O, Zhang MH, Vishnubhakat JM, Ombrellino M, Che JT, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999;285:248\u201351.","journal-title":"Science"},{"key":"2763_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature00858","volume":"418","author":"P Scaffidi","year":"2002","unstructured":"Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418:191\u20135.","journal-title":"Nature"},{"key":"2763_CR11","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3389\/fimmu.2018.00705","volume":"9","author":"SY Kim","year":"2018","unstructured":"Kim SY, Son M, Lee SE, Park IH, Kwak MS, Han M, et al. High-mobility group Box 1-induced complement activation causes sterile inflammation. Front Immunol. 2018;9:705.","journal-title":"Front Immunol"},{"key":"2763_CR12","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.cell.2014.04.019","volume":"157","author":"JA Rickard","year":"2014","unstructured":"Rickard JA, O\u2019Donnell JA, Evans JM, Lalaoui N, Poh AR, Rogers T, et al. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell. 2014;157:1175\u201388.","journal-title":"Cell"},{"key":"2763_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.chom.2015.01.002","volume":"17","author":"Z Huang","year":"2015","unstructured":"Huang Z, Wu SQ, Liang Y, Zhou X, Chen W, Li L, et al. RIP1\/RIP3 binding to HSV-1 ICP6 initiates necroptosis to restrict virus propagation in mice. Cell Host Microbe. 2015;17:229\u201342.","journal-title":"Cell Host Microbe"},{"key":"2763_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.126","volume":"6","author":"M Deutsch","year":"2015","unstructured":"Deutsch M, Graffeo CS, Rokosh R, Pansari M, Ochi A, Levie EM, et al. Divergent effects of RIP1 or RIP3 blockade in murine models of acute liver injury. Cell Death Dis. 2015;6:e1759.","journal-title":"Cell Death Dis"},{"key":"2763_CR15","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/cvr\/cvu146","volume":"103","author":"M Luedde","year":"2014","unstructured":"Luedde M, Lutz M, Carter N, Sosna J, Jacoby C, Vucur M, et al. RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction. Cardiovasc Res. 2014;103:206\u201316.","journal-title":"Cardiovasc Res"},{"key":"2763_CR16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.celrep.2012.12.012","volume":"3","author":"J Lin","year":"2013","unstructured":"Lin J, Li H, Yang M, Ren J, Huang Z, Han F, et al. A role of RIP3-mediated macrophage necrosis in atherosclerosis development. Cell Rep. 2013;3:200\u201310.","journal-title":"Cell Rep"},{"key":"2763_CR17","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/cdd.2013.109","volume":"21","author":"Y Murakami","year":"2014","unstructured":"Murakami Y, Matsumoto H, Roh M, Giani A, Kataoka K, Morizane Y, et al. Programmed necrosis, not apoptosis, is a key mediator of cell loss and DAMP-mediated inflammation in dsRNA-induced retinal degeneration. Cell Death Differ. 2014;21:270\u20137.","journal-title":"Cell Death Differ"},{"key":"2763_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41568-024-00674-x","volume":"24","author":"P Meier","year":"2024","unstructured":"Meier P, Legrand AJ, Adam D, Silke J. Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity. Nat Rev Cancer. 2024;24:299\u2013315.","journal-title":"Nat Rev Cancer"},{"key":"2763_CR19","first-page":"1289","volume":"47","author":"X Long","year":"2022","unstructured":"Long X, Zhu N, Qiu J, Yu X, Ruan X, Wang X, et al. Necroptosis in inflammatory bowel disease: a potential effective target. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022;47:1289\u201398.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"2763_CR20","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10208","volume":"474","author":"KJ Maloy","year":"2011","unstructured":"Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature. 2011;474:298\u2013306.","journal-title":"Nature"},{"key":"2763_CR21","doi-asserted-by":"publisher","first-page":"12526","DOI":"10.3748\/wjg.v20.i35.12526","volume":"20","author":"WK Saeed","year":"2014","unstructured":"Saeed WK, Jun DW. Necroptosis: an emerging type of cell death in liver diseases. World J Gastroenterol 2014;20:12526\u201332.","journal-title":"World J Gastroenterol"},{"key":"2763_CR22","doi-asserted-by":"publisher","first-page":"745","DOI":"10.12998\/wjcc.v6.i14.745","volume":"6","author":"S Li","year":"2018","unstructured":"Li S, Ning LG, Lou XH, Xu GQ. Necroptosis in inflammatory bowel disease and other intestinal diseases. World J Clin Cases. 2018;6:745\u201352.","journal-title":"World J Clin Cases"},{"key":"2763_CR23","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.dld.2017.08.017","volume":"49","author":"A Negroni","year":"2017","unstructured":"Negroni A, Colantoni E, Pierdomenico M, Palone F, Costanzo M, Oliva S, et al. RIP3 AND pMLKL promote necroptosis-induced inflammation and alter membrane permeability in intestinal epithelial cells. Dig Liver Dis. 2017;49:1201\u201310.","journal-title":"Dig Liver Dis"},{"key":"2763_CR24","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jhep.2019.11.008","volume":"72","author":"Majdi A","year":"2020","unstructured":"Majdi A, Aoudjehane L, Ratziu V, Islam T, Afonso MB, Conti F, et al. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease. J Hepatol. 2020;72:627\u201335.","journal-title":"J Hepatol"},{"key":"2763_CR25","doi-asserted-by":"crossref","unstructured":"Zhang B, Li MD, Yin R, Liu Y, Yang Y, Mitchell-Richards KA, et al. O-GlcNAc transferase suppresses necroptosis and liver fibrosis. JCI Insight. 2019;4:e127709.","DOI":"10.1172\/jci.insight.127709"},{"key":"2763_CR26","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1136\/gutjnl-2015-311247","volume":"66","author":"GW He","year":"2017","unstructured":"He GW, Gunther C, Kremer AE, Thonn V, Amann K, Poremba C, et al. PGAM5-mediated programmed necrosis of hepatocytes drives acute liver injury. Gut. 2017;66:716\u201323.","journal-title":"Gut"},{"key":"2763_CR27","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.fob.2014.08.007","volume":"4","author":"K Takemoto","year":"2014","unstructured":"Takemoto K, Hatano E, Iwaisako K, Takeiri M, Noma N, Ohmae S, et al. Necrostatin-1 protects against reactive oxygen species (ROS)-induced hepatotoxicity in acetaminophen-induced acute liver failure. FEBS Open Bio. 2014;4:777\u201387.","journal-title":"FEBS Open Bio"},{"key":"2763_CR28","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nrd.2015.6","volume":"15","author":"M Conrad","year":"2016","unstructured":"Conrad M, Angeli JP, Vandenabeele P, Stockwell BR. Regulated necrosis: disease relevance and therapeutic opportunities. Nat Rev Drug Discov. 2016;15:348\u201366.","journal-title":"Nat Rev Drug Discov"},{"key":"2763_CR29","first-page":"1","volume":"50","author":"HH Park","year":"2018","unstructured":"Park HH, Park SY, Mah S, Park JH, Hong SS, Hong S, et al. HS-1371, a novel kinase inhibitor of RIP3-mediated necroptosis. Exp Mol Med. 2018;50:1\u201315.","journal-title":"Exp Mol Med"},{"key":"2763_CR30","doi-asserted-by":"publisher","first-page":"31268","DOI":"10.1074\/jbc.M113.462341","volume":"288","author":"WJ Kaiser","year":"2013","unstructured":"Kaiser WJ, Sridharan H, Huang C, Mandal P, Upton JW, Gough PJ, et al. Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J Biol Chem. 2013;288:31268\u201379.","journal-title":"J Biol Chem"},{"key":"2763_CR31","doi-asserted-by":"publisher","first-page":"E7450","DOI":"10.1073\/pnas.1707531114","volume":"114","author":"S Liu","year":"2017","unstructured":"Liu S, Liu H, Johnston A, Hanna-Addams S, Reynoso E, Xiang Y, et al. MLKL forms disulfide bond-dependent amyloid-like polymers to induce necroptosis. Proc Natl Acad Sci USA. 2017;114:E7450\u2013E9.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2763_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13857","volume":"17","author":"ALA Sun","year":"2024","unstructured":"Sun ALA, Gillies JD, Shen Y, Deng H, Xue F, Ma Y, et al. A phase I randomized study to evaluate safety, pharmacokinetics, and pharmacodynamics of SIR2446M, a selective RIPK1 inhibitor, in healthy participants. Clin Transl Sci. 2024;17:e13857.","journal-title":"Clin Transl Sci"},{"key":"2763_CR33","doi-asserted-by":"publisher","DOI":"10.1111\/cts.70151","volume":"18","author":"OM Gonen","year":"2025","unstructured":"Gonen OM, Porter T, Wang B, Xue F, Ma Y, Song L, et al. Safety, pharmacokinetics and target engagement of a novel brain penetrant RIPK1 inhibitor (SIR9900) in healthy adults and elderly participants. Clin Transl Sci. 2025;18:e70151.","journal-title":"Clin Transl Sci"},{"key":"2763_CR34","doi-asserted-by":"crossref","unstructured":"Weisel K, Scott N, Berger S, Wang S, Brown K, Powell M, et al. A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis. BMJ Open Gastroenterol. 2021;8:e000680.","DOI":"10.1136\/bmjgast-2021-000680"},{"key":"2763_CR35","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1111\/cts.13317","volume":"15","author":"M Vissers","year":"2022","unstructured":"Vissers M, Heuberger J, Groeneveld GJ, Oude Nijhuis J, De Deyn PP, Hadi S, et al. Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo-controlled, double-blind phase I\/Ib studies in healthy subjects and patients. Clin Transl Sci. 2022;15:2010\u201323.","journal-title":"Clin Transl Sci"},{"key":"2763_CR36","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s40263-019-00661-z","volume":"33","author":"F Carbone","year":"2019","unstructured":"Carbone F, Djamshidian A, Seppi K, Poewe W. Apomorphine for Parkinson\u2019s disease: efficacy and safety of current and new formulations. CNS Drugs. 2019;33:905\u201318.","journal-title":"CNS Drugs"},{"key":"2763_CR37","doi-asserted-by":"publisher","first-page":"807","DOI":"10.14336\/AD.2018.0728","volume":"10","author":"XX Deng","year":"2019","unstructured":"Deng XX, Li SS, Sun FY. Necrostatin-1 prevents necroptosis in brains after ischemic stroke via inhibition of RIPK1-mediated RIPK3\/MLKL signaling. Aging Dis. 2019;10:807\u201317.","journal-title":"Aging Dis"},{"key":"2763_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.130","volume":"6","author":"A Fauster","year":"2015","unstructured":"Fauster A, Rebsamen M, Huber KV, Bigenzahn JW, Stukalov A, Lardeau CH, et al. A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis. Cell Death Dis. 2015;6:e1767.","journal-title":"Cell Death Dis"},{"key":"2763_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.113030","volume":"212","author":"Y Wang","year":"2021","unstructured":"Wang Y, Ma H, Huang J, Yao Z, Yu J, Zhang W, et al. Discovery of bardoxolone derivatives as novel orally active necroptosis inhibitors. Eur J Med Chem. 2021;212:113030.","journal-title":"Eur J Med Chem"},{"key":"2763_CR40","doi-asserted-by":"publisher","first-page":"252","DOI":"10.4103\/1673-5374.226394","volume":"13","author":"SA Cruz","year":"2018","unstructured":"Cruz SA, Qin Z, Stewart AFR, Chen HH. Dabrafenib, an inhibitor of RIP3 kinase-dependent necroptosis, reduces ischemic brain injury. Neural Regen Res. 2018;13:252\u20136.","journal-title":"Neural Regen Res"},{"key":"2763_CR41","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.molcel.2014.03.003","volume":"54","author":"HY Wang","year":"2014","unstructured":"Wang HY, Sun LM, Su LJ, Rizo J, Liu L, Wang LF, et al. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Molecular Cell. 2014;54:133\u201346.","journal-title":"Molecular Cell"},{"key":"2763_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0733-4","volume":"9","author":"RZ Li","year":"2018","unstructured":"Li RZ, Fan XX, Duan FG, Jiang ZB, Pan HD, Luo LX, et al. Proscillaridin A induces apoptosis and suppresses non-small-cell lung cancer tumor growth via calcium-induced DR4 upregulation. Cell Death Dis. 2018;9:696.","journal-title":"Cell Death Dis"},{"key":"2763_CR43","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/S0278-5846(01)00188-9","volume":"25","author":"NM Ng Ying Kin","year":"2001","unstructured":"Ng Ying Kin NM, Lal S, Thavundayil JX. Stability of apomorphine hydrochloride in aqueous sodium bisulphite solutions. Prog Neuropsychopharmacol Biol Psychiatry. 2001;25:1461\u20138.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2763_CR44","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/cdd.2015.169","volume":"23","author":"MC Tanzer","year":"2016","unstructured":"Tanzer MC, Matti I, Hildebrand JM, Young SN, Wardak A, Tripaydonis A, et al. Evolutionary divergence of the necroptosis effector MLKL. Cell Death Differ. 2016;23:1185\u201397.","journal-title":"Cell Death Differ"},{"key":"2763_CR45","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.molcel.2018.05.010","volume":"70","author":"CM Dovey","year":"2018","unstructured":"Dovey CM, Diep J, Clarke BP, Hale AT, McNamara DE, Guo H, et al. MLKL requires the inositol phosphate code to execute necroptosis. Mol Cell. 2018;70:936\u201348 e7.","journal-title":"Mol Cell"},{"key":"2763_CR46","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.str.2014.07.014","volume":"22","author":"L Su","year":"2014","unstructured":"Su L, Quade B, Wang H, Sun L, Wang X, Rizo J. A plug release mechanism for membrane permeation by MLKL. Structure. 2014;22:1489\u2013500.","journal-title":"Structure"},{"key":"2763_CR47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/0023677215570992","volume":"49","author":"JC Mossanen","year":"2015","unstructured":"Mossanen JC, Tacke F. Acetaminophen-induced acute liver injury in mice. Lab Anim. 2015;49:30\u20136.","journal-title":"Lab Anim"},{"key":"2763_CR48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.mito.2019.07.006","volume":"49","author":"A Miyauchi","year":"2019","unstructured":"Miyauchi A, Kouga T, Jimbo EF, Matsuhashi T, Abe T, Yamagata T, et al. Apomorphine rescues reactive oxygen species-induced apoptosis of fibroblasts with mitochondrial disease. Mitochondrion. 2019;49:111\u201320.","journal-title":"Mitochondrion"},{"key":"2763_CR49","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1038\/s41598-024-55293-1","volume":"14","author":"A Miyauchi","year":"2024","unstructured":"Miyauchi A, Watanabe C, Yamada N, Jimbo EF, Kobayashi M, Ohishi N, et al. Apomorphine is a potent inhibitor of ferroptosis independent of dopaminergic receptors. Sci Rep. 2024;14:4820.","journal-title":"Sci Rep"},{"key":"2763_CR50","doi-asserted-by":"publisher","first-page":"10108","DOI":"10.3390\/ijms241210108","volume":"24","author":"V Martinez-Osorio","year":"2023","unstructured":"Martinez-Osorio V, Abdelwahab Y, Ros U. The many faces of MLKL, the executor of necroptosis. Int J Mol Sci. 2023;24:10108.","journal-title":"Int J Mol Sci"},{"key":"2763_CR51","doi-asserted-by":"publisher","first-page":"33272","DOI":"10.1073\/pnas.2017406117","volume":"117","author":"M Rubbelke","year":"2020","unstructured":"Rubbelke M, Fiegen D, Bauer M, Binder F, Hamilton J, King J, et al. Locking mixed-lineage kinase domain-like protein in its auto-inhibited state prevents necroptosis. Proc Natl Acad Sci USA. 2020;117:33272\u201381.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2763_CR52","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1002\/jps.2600690830","volume":"69","author":"RE Wilcox","year":"1980","unstructured":"Wilcox RE, Humphrey DW, Riffee WH, Smith RV. Stability of apomorphine in solutions containing ascorbic acid and bisulfite and effects of antioxidants on apomorphine-induced cage climbing and hypothermia in mice. J Pharm Sci. 1980;69:974\u20136.","journal-title":"J Pharm Sci"},{"key":"2763_CR53","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/j.1552-4604.1978.tb02427.x","volume":"18","author":"JD Proctor","year":"1978","unstructured":"Proctor JD, Chremos AN, Evans EF, Wasserman AJ. An apomorphine-induced vomiting model for antiemetic studies in man. J Clin Pharm. 1978;18:95\u20139.","journal-title":"J Clin Pharm"},{"key":"2763_CR54","doi-asserted-by":"publisher","first-page":"e60537","DOI":"10.1371\/journal.pone.0060537","volume":"8","author":"CC Horn","year":"2013","unstructured":"Horn CC, Kimball BA, Wang H, Kaus J, Dienel S, Nagy A, et al. Why can\u2019t rodents vomit? A comparative behavioral, anatomical, and physiological study. PLoS One. 2013;8:e60537.","journal-title":"PLoS One"},{"key":"2763_CR55","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1039\/b204605a","volume":"2","author":"JMPJ Garrido","year":"2002","unstructured":"Garrido JMPJ, Delerue-Matos C, Borges F, Macedo TRA, Oliveira-Brett AM. New insights into the oxidation pathways of apomorphine. J Chem Soc Perk T. 2002;2:1713\u20137.","journal-title":"J Chem Soc Perk T"},{"key":"2763_CR56","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/BF00197809","volume":"6","author":"F Delaglio","year":"1995","unstructured":"Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR. 1995;6:277\u201393.","journal-title":"J Biomol NMR"},{"key":"2763_CR57","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1093\/bioinformatics\/btu830","volume":"31","author":"W Lee","year":"2015","unstructured":"Lee W, Tonelli M, Markley JL. NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy. Bioinformatics. 2015;31:1325\u20137.","journal-title":"Bioinformatics"},{"key":"2763_CR58","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1111\/febs.16360","volume":"289","author":"MS Lee","year":"2022","unstructured":"Lee MS, Lee SO, Choi J, Ryu M, Lee MK, Kim JH, et al. MUL1-RING recruits the substrate, p53-TAD as a complex with UBE2D2-UB conjugate. FEBS J. 2022;289:3568\u201386.","journal-title":"FEBS J"},{"key":"2763_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.172992","volume":"873","author":"J Zhang","year":"2020","unstructured":"Zhang J, Lei H, Hu X, Dong W. Hesperetin ameliorates DSS-induced colitis by maintaining the epithelial barrier via blocking RIPK3\/MLKL necroptosis signaling. Eur J Pharm. 2020;873:172992.","journal-title":"Eur J Pharm"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02763-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02763-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02763-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T08:02:58Z","timestamp":1760342578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02763-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2763"],"URL":"https:\/\/doi.org\/10.1038\/s41420-025-02763-8","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with relevant guidelines and regulations. C57BL\/6 and BALB\/c mice were used following procedures approved by the Institutional Animal Care and Use Committee (IACUC) of the Yonsei Laboratory Animal Research Center (YLARC, 2018-0024). MLKL\n                      \u2013\/\u2013\n                      C57BL\/6 mice were used following procedures approved by the IACUC of the Laboratory Animal Research Center (LARC) of Ajou University Medical Center (2023-0053). No human participants were involved in this study; therefore, informed consent was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"457"}}